Ion Diagnostics LLC was founded to develop novel diagnostic technologies based on real-time examination of living cells. We use discoveries from the the emerging science of bioelectricity to create new products to improve human health. Our first product is a new kind of cancer diagnositc test that is fast, inexpensive, and simple to use.
Pathology is too expensive and too slow. We need to speed up the methods we already have, but more urgently, we need brand new methods. The vast majority of commonly used and in-development technologies rely on dead cells or parts of dead cells, for example their DNA or proteins. This means that decades of brilliant research on living cells is being grossly underutilized in medicine.
Membrane Voltage Profiling with Tissue Printing is a fast, simple, inexpensive, five-step procedure that provides critical information to the surgeon and the pathologist during surgery. It can also be used with core biopsies.
We have sumbitted patent applications for both the Akita dye, AVID44 and for MVP and MVP-TP.
 rapid;  inexpensive;  built on discoveries about living cells;  uses commonly available fluorescence microscopy; and  does not interfere with current methodology or standards of care.
For health care providers interested in testing MVP, Ion Diagnostics will perform MVP as a service. Ongoing MVP will also be available as an ongoing service. Contact us for more information.
Akita Innovations, co-founded by two of our founders, Larry Takiff and Lawrence Hancock, created and will provide the high quality voltage sensitive dye, AVID44. Indeed AVID stands for Akita Voltage Indicator Dye.
Our customers will be pathologists and surgeons, hospitals, clinics and any health care provider interested in point-of-service diagnostics. Researchers studying aspects of membrane voltage will be helped with their research because of the standardization MVP provides. Finally, anyone interested in using membrane voltage as an assay during drug development will also appreciate the economy, ease of use, and speed of MVP.
Standard operating procedures for Tissue Printing are establsihed. Standard operating procedures for MVP of cultured cell lines are in the final stages of testing, and images to be used for establishing the best classifiers for image analysis are complete. Establishing standard operating procedures for using MVP on human biopsies will continue once hospitals reopen at the end of the Covid-19 situation.